Pharma and Healthcare - Q2FY27E: Result Preview
We expect pharmaceutical companies under our coverage to deliver a subdued yet positive performance in Q2FY27, with aggregate revenue rising 7.0%...
90 Views
Primer: Aurobindo Pharma (ARBP IN) - Aug 2026
Aurobindo Pharma is a major player in the U.S. generics market, leveraging its large-scale, vertically integrated manufacturing model to...
114 Views
The "Mother of All Deals": India-EU FTA as a Structural Alpha Trigger
​India signs game-changing FTA with EU, boosting key industries like textiles and auto components while facing challenges of non-tariff barriers...
259 Views
India Equities: Stocks to Watch After Deep Underperformance
India looks attractive after a historic washout. We prefer to position among leaders in the middle of the index, scaling up as breadth improves....
104 Views
Aurobindo Pharma Ltd - Operational Beat
US Injectables segment also reported healthy growth of 17% YoY, while Europe formulations emerged as the key growth engine, delivering strong 27.4%...
136 Views